Metastatic Melanoma
Showing NaN - NaN of 18
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib
- +4 more
-
Phoenix, Arizona
- +48 more
Jan 3, 2023
Metastatic Melanoma Trial in Lancaster, Philadelphia (Hypofractionated Radiation Therapy (HFRT), Nivolumab, Ipilimumab)
Recruiting
- Metastatic Melanoma
- Hypofractionated Radiation Therapy (HFRT)
- +2 more
-
Lancaster, Pennsylvania
- +1 more
Mar 30, 2022
Metastatic Melanoma Trial in United States (TLPLDC Vaccine)
Completed
- Metastatic Melanoma
- TLPLDC Vaccine
-
Birmingham, Alabama
- +6 more
Sep 12, 2021
Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))
Completed
- Metastatic Melanoma
- MORAb-004 (monoclonal antibody)
-
Scottsdale, Arizona
- +28 more
Aug 6, 2021
Metastatic Melanoma Trial in Philadelphia (Ipilimumab, Stereotactic Body Radiation Therapy)
Completed
- Metastatic Melanoma
- Ipilimumab
- Stereotactic Body Radiation Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the Universirty of Pennsylvania
Jul 19, 2021
Metastatic Melanoma Trial in Duarte, Portland, Philadelphia (Bempegaldesleukin (NKTR-214), Nivolumab, 8?Zr-Df-IAB22M2C)
Withdrawn
- Metastatic Melanoma
- Bempegaldesleukin (NKTR-214)
- +2 more
-
Duarte, California
- +2 more
Jun 28, 2021
Metastatic Melanoma Trial in Worldwide (Lifileucel)
Active, not recruiting
- Metastatic Melanoma
- Lifileucel
-
La Jolla, California
- +56 more
Mar 24, 2021
Imaging FDG Flare in Melanoma
Completed
- Metastatic Melanoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 7, 2020
Nausea and Vomiting In Patients Receiving Consecutive Days of
Terminated
- Metastatic Melanoma
- Nausea
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Oct 19, 2016
Metastatic Melanoma Trial in Philadelphia (Obatoclax Mesylate, Temozolomide)
Terminated
- Metastatic Melanoma
- Obatoclax Mesylate
- Temozolomide
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 20, 2016
Metastatic Melanoma Trial in Philadelphia (131-I-MIP-1145)
Terminated
- Metastatic Melanoma
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 7, 2011